MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30
Rhea-AI Summary
MIMEDX Group (Nasdaq: MDXG) has announced its upcoming first quarter 2025 financial results release and conference call schedule. The company will disclose its operating and financial results for Q1 2025 (ended March 31) after market close on Wednesday, April 30, 2025.
The senior management team will host a webcast and conference call at 4:30 p.m. Eastern Time on the same day. Investors can access the call through dedicated U.S. (877-407-6184) and International (201-389-0877) lines using Conference ID 13752696. A replay of the webcast will be available on www.mimedx.com for approximately 30 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MDXG declined 2.50%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MARIETTA, Ga., April 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2025 after the market close on Wednesday, April 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13752696
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
When will MIMEDX (MDXG) release its Q1 2025 earnings?
What time is MIMEDX's Q1 2025 earnings conference call?
How can investors access MIMEDX's Q1 2025 earnings call?
How long will MIMEDX's Q1 2025 earnings call replay be available?
